Andere talen Corline Biomedical AB

Aandelen

CLBIO

SE0006887451

Vertraagde tijd Nasdaq Stockholm Andere beurzen 14:35:12 03-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
12,9 ^SEK	-3,37%		+6,61%	-13,42%

30/04	Corline Biomedical AB rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
14/02	Corline Biomedical AB rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/02
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24-08-23
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	24-02-23
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2022	24-02-23
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25-11-22
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25-08-22
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022	13-05-22
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	23-02-22
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	25-11-21
Corline Biomedical AB Reports Earnings Results for the Second Quarter Ended June 30, 2021	25-08-21
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2021	10-05-21
Corline Biomedical AB announced that it has received SEK 35.475 million in funding from M2 Asset Management AB, HealthInvest Partners AB, and other investors	30-03-21
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	26-02-21
Corline Biomedical AB to Enter into Agreement with the Clinical Islet Transplant Program at University of Alberta	05-07-17
Corline Biomedical AB to Enter into Agreement with Nuffield Department of Surgical Sciences	30-06-17
Corline Biomedical AB has completed an IPO in the amount of SEK 12.04 million.	28-04-15

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Corline Biomedical AB

Aandelen

CLBIO

SE0006887451

Andere talen

Filters